Kevin Cook, Sterling Pharma Solutions CEO
British CDMO Sterling partners up on low-cost manufacturing of molnupiravir
A British CDMO and the University of Manchester have teamed up to support the development of low-cost manufacturing of molnupiravir, the antiviral pill for Covid …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.